ScholarIQanswers from OpenAlex

Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis

PaperCitations, authors & open-access status

Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis have?

ScholarIQcitation count

Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis has 15 citations in the OpenAlex counts ScholarIQ stores.

When was Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis published?

ScholarIQyear

Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis has 2020 year in the ScholarIQ index.

What is the open-access status of Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis?

ScholarIQoa status

Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis has bronze oa status in the ScholarIQ index.

What is the DOI of Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis?

ScholarIQdoi

The DOI for Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis is on the source record.

What is the PMID of Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis?

ScholarIQpmid

The PMID for Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis is on the source record.

What is the OpenAlex record for Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis?

ScholarIQopenalex

The OpenAlex for Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial